To the full analysis
Shanghai United Imaging Healthcare stock: growth
688271.SSShanghai United Imaging Healthcare reported $2.07B in revenue for fiscal 2025, up 34% on the prior year, up 19.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
31.4%
per year from 2018 to 2025
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 19.2% | 31.4% |
| Revenue per share | 15.4% | no data |
| Earnings | 15.7% | no data |
| Earnings per share | 11.7% | no data |
| Free cash flow | −25.8% | no data |
| Free cash flow per share | −28.2% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $305.18M | −$18.86M | −$52.35M |
| 2019 | $442.21M | −$11.02M | −$58.64M |
| 2020 | $859.01M | $135.36M | $390.84M |
| 2021 | $1.09B | $212.44M | $89.3M |
| 2022 | $1.39B | $248.35M | −$8.78M |
| 2023 | $1.71B | $296.07M | −$141.46M |
| 2024 | $1.54B | $189.24M | −$384.62M |
| 2025 | $2.07B | $280.33M | $87.85M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Jul 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.